当前位置:首页 - 行情中心 - 迈普医学(301033) - 财务分析 - 现金流量表

迈普医学

(301033)

  

流通市值:29.99亿  总市值:35.63亿
流通股本:5693.51万   总股本:6763.10万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金326,900,100.15206,831,959.693,575,718.62401,608,194.11
  收到的税费返还4,388.71--1,066,476.67
  收到其他与经营活动有关的现金5,409,221.613,390,308.741,010,502.3412,056,406.3
  经营活动现金流入小计332,313,710.47210,222,268.3494,586,220.96414,731,077.08
  购买商品、接受劳务支付的现金49,944,432.5735,499,338.6821,510,286.9457,071,846.78
  支付给职工以及为职工支付的现金93,773,885.1965,147,774.4837,993,484.198,752,712.67
  支付的各项税费40,088,033.0824,521,868.1413,926,775.0849,686,739.3
  支付其他与经营活动有关的现金59,237,894.4136,850,699.1317,953,449.8469,353,099.76
  经营活动现金流出小计243,044,245.25162,019,680.4391,383,995.96274,864,398.51
  经营活动产生的现金流量净额89,269,465.2248,202,587.913,202,225139,866,678.57
二、投资活动产生的现金流量:
  收回投资收到的现金428,571,677.1258,365,246.45123,034,078.62560,349,186.13
  取得投资收益收到的现金120,70192,63062,790-
  处置固定资产、无形资产和其他长期资产收回的现金净额---80,825.94
  投资活动现金流入小计428,692,378.1258,457,876.45123,096,868.62560,430,012.07
  购建固定资产、无形资产和其他长期资产支付的现金33,790,633.1421,018,607.57,917,432.8523,819,716.8
  投资支付的现金410,211,898216,807,24175,976,062682,225,852
  投资活动现金流出小计444,002,531.14237,825,848.583,893,494.85706,045,568.8
  投资活动产生的现金流量净额-15,310,153.0420,632,027.9539,203,373.77-145,615,556.73
三、筹资活动产生的现金流量:
  吸收投资收到的现金14,416,251.2--12,626,905.05
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计14,416,251.2--12,626,905.05
  分配股利、利润或偿付利息支付的现金46,765,485.946,765,485.9-39,700,158.6
  支付其他与筹资活动有关的现金64,123.3812,720-1,122,214.95
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计46,829,609.2846,778,205.9-40,822,373.55
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-32,413,358.08-46,778,205.9--28,195,468.5
四、汇率变动对现金及现金等价物的影响-883,559.18-648,129.59-360,776.12321,959.72
五、现金及现金等价物净增加额40,662,394.9221,408,280.3742,044,822.65-33,622,386.94
  加:期初现金及现金等价物余额19,595,214.3319,595,214.3319,595,214.3353,217,601.27
  期末现金及现金等价物余额60,257,609.2541,003,494.761,640,036.9819,595,214.33
补充资料:
  净利润-56,580,533.57-113,128,438.52
  资产减值准备-1,006,631.93-2,877,417.21
  固定资产和投资性房地产折旧-9,102,148.15-18,549,801.21
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,102,148.15-18,549,801.21
  无形资产摊销-4,156,733.66-8,136,198.17
  长期待摊费用摊销-199,261.76-572,942.03
  处置固定资产、无形资产和其他长期资产的损失----6,437.07
  固定资产报废损失--69,694.2-2,697,376.44
  公允价值变动损失--291,865.26--185,028.55
  财务费用-671,470.49--727,437.27
  投资损失--1,711,902.97--2,938,077.08
  递延所得税--164,385.77-97,826.88
  其中:递延所得税资产减少--1,616,430.4-108,179.18
    递延所得税负债增加-1,452,044.63--10,352.3
  存货的减少--6,898,097.03--5,287,744.67
  经营性应收项目的减少--5,350,751.5--3,934,790.29
  经营性应付项目的增加--9,335,890.08--3,407,332.82
  其他---9,485,037.21
  现金的期末余额-41,003,494.7-19,595,214.33
  减:现金的期初余额-19,595,214.33-53,217,601.27
  现金及现金等价物的净增加额-21,408,280.37--33,622,386.94
公告日期2026-10-222026-08-212026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑